Fierce Pharma

AUGUST 16, 2024

Even as supplies of Novo Nordisk’s immensely popular GLP-1 drugs Ozempic and Wegovy start to stabilize, the Danish drugmaker continues to announce manufacturing and capacity upgrades at a rapid cli | Novo Nordisk Pharmatech, a unit that specializes in producing drug ingredients, is spending 1.5 billion Danish kroner ($220 million) to build a plant in Køge, Denmark, that will make raw materials, the company said Friday.

Specialization 287

Specialization Manufacturing 287

MedCity News

AUGUST 16, 2024

To change the trajectory of the youth mental health pandemic, we must commit to “bending the curve” by building strong, prevention-oriented partnerships. Collaboration between caretakers, schools, and mental health professionals is vital. The post Bend the Curve: Schools’ Crucial Role in Early Intervention for Youth Mental Health appeared first on MedCity News.

Physicians 115

Physicians Patients 115

Fierce Pharma

AUGUST 16, 2024

After knocking out multiple personal injury lawsuits this summer, GSK has prevailed on another front in its long-running Zantac litigation. | After knocking out multiple personal injury lawsuits this summer, GSK has prevailed on another front in its long-running Zantac litigation, thanks to a decision in Florida that put the kibosh on suspect expert testimony.

283

283

MedCity News

AUGUST 16, 2024

Abbott and Medtronic — typically regarded as competitors — have recently joined forces. The two companies teamed up to collaborate on a continuous glucose monitoring system that combines Abbott’s FreeStyle Libre technology with Medtronic’s automated insulin delivery system. The post When Foes Become Friends: Abbott Teams Up With Medtronic appeared first on MedCity News.

109

109

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Fierce Pharma

AUGUST 16, 2024

AstraZeneca has scored an FDA approval in the advancement of its hi | AstraZeneca has scored an FDA approval in the advancement of its high-flying cancer therapy Imfinzi that comes with some controversy. The nod is for Imfinzi to treat patients with resectable non-small cell lung cancer perioperatively.

FDA 262

FDA Patients 262

Pharmaceutical Commerce

AUGUST 16, 2024

In the final part of his Pharma Commerce video interview, Michael Rowe, Two Labs’ Senior Director of DSCSA/Serialization Compliance Services, comments on other ways to limit ‘bad actors’ attempts to sneak counterfeit drugs into the supply chain, aside from the DSCSA.

Pharma 105

Pharma 105

MedCity News

AUGUST 16, 2024

Fair Square Medicare launched a new generative AI platform called Vox. It’s meant to be used by Medicare carriers and brokerages and has three main features: AI voice agents, generative AI-driven insights and AI-powered coaching. The post Fair Square Medicare Unveils Generative AI Platform for Medicare Organizations appeared first on MedCity News.

108

108

Fierce Pharma

AUGUST 16, 2024

Merck licensed a bispecific from a Chinese biotech with plans to target oncology and autoimmune diseases. Legend Biotech is taking a close at its business as M&A has emerged as an option. | Merck licensed a bispecific from a Chinese biotech with plans to target oncology and autoimmune diseases. Legend Biotech is taking a close at its business as M&A has emerged as an option.

FDA 227

FDA Pharma 227

MedCity News

AUGUST 16, 2024

Despite achieving strong responses against influenza A, a Phase 3 test of a Pfizer and BioNTech flu and Covid-19 combination vaccine did not meet goals against less common influenza B. These results come two months after Moderna’s combination vaccine succeeded in its Phase 3 trial. The post Pfizer, BioNTech Flu and Covid-19 Combo Vaccine Falls Short Against Influenza B Strain appeared first on MedCity News.

Biopharma 106

Biopharma Pharma 106

Fierce Pharma

AUGUST 16, 2024

Months after securing the full rights to anti-CD19 antibody Monjuvi (tafasitamab) from partner MorphoSys, Incyte has the data to potentially back a label expansion into lymphoma. | The company looks to file its drug for a follicular lymphoma indication as part of a later-line triple combo therapy by the end of the year.

191

191

Advertisement

Pharmaceutical Commerce

AUGUST 16, 2024

By 2026, the first 10 drugs for individuals with Part D coverage—whose medications are mainly used to treat cancer, diabetes, and heart disease—will see discounts off of list prices ranging from 38-79%.

Medical 98

Medical 98

Fierce Pharma

AUGUST 16, 2024

Multiple sclerosis (MS) treatment could be on the brink of a significant breakthrough thanks to innovative research by Immunic Therapeutics. | Immunic Therapeutics CEO Daniel Vitt details the firm’s new oral MS therapy, vidofludimus calcium. Learn how this dual-action treatment could revolutionize MS care by addressing both relapses and disease progression.

130

130

MedCity News

AUGUST 16, 2024

Check out news from Alpha Sophia, MD Ally, Guardoc Health, and more. The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.

Healthcare 105

Healthcare Healthcare 105

Pharmatutor

AUGUST 16, 2024

The New Penal Processes in Pharmacy Act admin Fri, 08/16/2024 - 15:29 ABOUT AUTHOR Dr. R. S. Thakur Former Secretary, Pharmacy Council of India. Email : drramsthakur@gmail.

93

93

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales

MedCity News

AUGUST 16, 2024

A culture of compliance means truly valuing an adherence to industry standards, rather than looking at SOPs as a series of boxes that need to be checked in order to claim that requirements have been met. The post Corporate Compliance in the Era of TEFCA appeared first on MedCity News.

97

97

Pharmaceutical Technology

AUGUST 16, 2024

The FDA approval of Imfinzi in this indication comes a month after the agency called for an overhaul of perioperative lung cancer trials.

FDA 105

FDA 105

pharmaphorum

AUGUST 16, 2024

AstraZeneca has claimed FDA approval for its immunotherapy Imfinzi before and after surgery for non-small cell lung cancer, setting up a contest with MSD's rival Keytruda.PD-L1 inhibitor Imfinzi (durvalumab) has been cleared for use in adult patients who need surgery for early-stage (IIA-IIIB) NSCLC and have no ALK or EGFR mutations that would make them suitable for targeted therapies.

FDA 94

FDA Patients 94

Pharmaceutical Technology

AUGUST 16, 2024

While the vaccine demonstrated high responses for neutralizing influenza A titers, it failed to show sufficient efficacy against influenza B.

98

98

Advertisement

Distribution

pharmaphorum

AUGUST 16, 2024

As WHO declares mpox an emergency, the only recognised drug treatment for the virus, Siga's tecovirimat, fails a clinical trial.

98

98

Pharmaceutical Technology

AUGUST 16, 2024

Genomic medicines offer new techniques for treating conditions once thought to be intractable - a world of opportunity awaits.

Medicine 98

Medicine 98

pharmaphorum

AUGUST 16, 2024

Joe Biden and Kamala Harris reaffirm commitment to Medicare drug pricing negotiations in first joint rally since ticket swap.

98

98

Pharmaceutical Technology

AUGUST 16, 2024

Bavarian Nordic aims to gain a label expansion for adolescents in Europe in Q4 this year, whilst it prepares a trial in children in Africa.

72

72

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

pharmaphorum

AUGUST 16, 2024

Lykos Therapeutics is slashing staff after the FDA turned down its MDMA-assisted therapy for PTSD, while founder Rick Doblin is stepping down.

FDA 89

FDA 89

PharmaTimes

AUGUST 16, 2024

The study yielded over one million dose-responsive curves for existing cancer drugs

Medicine 93

Medicine 93

Pharmaceutical Commerce

AUGUST 16, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma 105

Clear Pivot

AUGUST 16, 2024

When I've been talking with prospects over the past few months, I've been seeing increasing confusion in what types of sales and marketing email tools there are and how they should be used. But it is VERY important to know the differences and why. If you use the wrong tools for the wrong job, you could cause some real damage, including even getting suspended by your email marketing provider or burning down your email domain reputation.

Prospecting 52

Prospecting Sales Marketing 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

European Pharmaceutical Review

AUGUST 16, 2024

Rayne Waller will be joining the Genmab A/S Executive Committee as Executive Vice President and Chief Technology Officer. The company stated that the creation of this new role in its committee will support Genmab’s innovation development as a biotech firm. In addition, Executive Vice President and Chief Operating Officer Anthony Mancini will step down, “to pursue other opportunities”, according to the company.

Manufacturing 52

Manufacturing Distribution Management Government 52

Clear Pivot

AUGUST 16, 2024

When I've been talking with prospects over the past few months, I've been seeing increasing confusion in what types of sales and marketing email tools there are and how they should be used. But it is VERY important to know the differences and why. If you use the wrong tools for the wrong job, you could cause some real damage, including even getting suspended by your email marketing provider or burning down your email domain reputation.

Prospecting 52

Prospecting Sales Marketing 52

PharmaTech

AUGUST 16, 2024

A Phase III study showed that 62% of patients given Livdelzi achieved the primary endpoint of composite biochemical response after 12 months, compared to 20% of participants taking placebo.

FDA 52

FDA Patients 52

PharmExec

AUGUST 16, 2024

Pharm Exec’s latest sampling of notable biopharma brand approvals and launches all have unique stories to tell—from the winding journeys to innovative “firsts” to new momentum for milestones to come.

Biopharma 52

Biopharma 52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety